HRS-6257

HRS-6257 · Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-6257, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects [Phase 1]